Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Whitehawk Therapeutics stock has a consensus rating of "Buy" and an average price target of $7.50. The average 1-year stock price forecast is 94.81% higher than the current stock price, while the lowest is $4.00 (+3.90%) and the highest is $10 (+159.74%).

Price Target: $7.50 (+94.81%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.00$7.50$7.50$10
Change+3.90%+94.81%+94.81%+159.74%

Analyst Ratings

The average analyst rating for Whitehawk Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy222234
Buy001111
Hold333333
Sell000000
Strong Sell000000
Total556678

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Initiates
$9
BuyInitiates$9+133.77%Jul 13, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$10
BuyInitiates$10+159.74%Jun 25, 2026
JonesTrading
JonesTrading
Buy
Maintains
$7
BuyMaintains$7+81.82%May 22, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$6$7
BuyReiterates$6$7+81.82%May 8, 2026
TD Cowen
TD Cowen
Hold
Maintains
n/a
HoldMaintainsn/an/aMay 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
-1.13M
from 7.15M
Revenue Next Year
-1.14M
from -1.13M
EPS This Year
-1.11
from -1.74
EPS Next Year
-1.10
from -1.11
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.12M15.22M24.35M25.98M7.15M-1.13M
Operating Income
-37.06M-58.96M-71.93M-64.82M-114.40M-101.80M
Net Income
-110.09M-60.51M-65.77M-63.69M-20.60M-95.47M
EPS
-----1.74-1.11
Free Cash Flow
-15.23M-29.52M-37.70M-38.69M-53.65M-111.47M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avg-1.1M
Low-9.0M

Revenue Growth

Revenue Growth202620272028
High
-100.0%
Avg-
Low-

EPS Forecast

EPS202620272028
High-0.99
Avg-1.11
Low-1.21

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-